Engaging Patients to Improve Genetic Risk Assessment and Testing
Preliminary results of a study comparing outreach methods for engaging patients in genetic risk assessment and testing are presented.
Genetic Testing
Factors Associated With Increased Distress and Uncertainty in Individuals Undergoing Multigene Genetic Testing
Survey study measured factors that affect levels of distress and uncertainty in a diverse population of patients undergoing multigene hereditary cancer testing.
Expert Panel Provides Guidance on Prostate Cancer Genetic Testing
A panel of experts agreed that men with metastatic prostate cancer may be the most appropriate candidates for comprehensive genetic testing.
Genetic Testing Recommended for All Men With Metastatic Prostate Cancer
New recommendations from an international consensus conference call for genetic testing of all men with metastatic prostate cancer (PCa) and those with a family history indicative of hereditary PCa and suggest strategies for genetic evaluation.
ASCO: At-Home Ovarian, Breast Cancer Genetic Testing Feasible
Testing without the traditional office visits and counseling poses no additional stress to women.
Genetic Testing Proposed for All Women ≤65 With Breast Cancer
Expanded testing could increase detection of carriers for BRCA1/2, mutations in other predisposition genes.
DTC Genetic Tests: High Rate of False-Negative Results May Hide a Clinical Pearl
Before you discount the results of a DTC genetic test, explore your patient’s reason for undergoing the testing and consider the appropriateness of a referral for medical-grade testing.
Multigene Testing for All Breast Cancer Patients Cost-Effective
Findings support expansion of genetic testing to all women with breast cancer.
How Culturally Competent Care Is Different for Jewish Women With Breast Cancer
A review of the cultural and religious beliefs of Ashkenazi Jewish women that may challenge adherence to breast cancer screening and genetic testing recommendations.
Molecular Features May Predict Response in Primary Pancreatic Cancer
The goal of this study was to determine how molecular features change when PDAC progresses from a primary tumor to metastatic disease.
- Loading...
Loading...
Loading... 
Loading...